contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


katarina-ageborg-new-chairman-of-the-board-and-markus-granlund-new-acting-ceo-of-tfs-healthscience

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Ratos operates in the investment industry and focuses on long-term ownership investments in Nordic companies, with a focus on acquiring and developing unlisted companies in the Nordic region. The company's portfolio includes companies in sectors such as industry, technology and consumer goods. The operations are primarily concentrated in the Nordic region. Ratos was founded in 1934 and is headquartered in Stockholm.

Ratos

Ratos has appointed Katarina Ageborg as the new Chairman of the Board and Markus Granlund as the new acting CEO of TFS HealthScience (TFS). Markus, who has been a Board member of TFS since October...

<div class="mfn-preamble"><p><strong>Ratos has appointed Katarina Ageborg as the new Chairman of the Board and Markus Granlund as the new acting CEO of TFS HealthScience (TFS). Markus, who has been a Board member of TFS since October 2024, assumes his new role today. TFS’s former CEO Bassem Saleh is leaving for new challenges outside the company.</strong></p></div><div class="mfn-body"><p>Katarina has solid and extensive experience of the life science sector having served 25 years in various senior positions in Astra Zeneca, the last few years of which as a member of global Group management as Sustainability and Chief Compliance Officer. She was also CEO of Astra Zeneca in Sweden between 2018 and 2023.</p><p>Markus Granlund is a seasoned leader and Board member with extensive strategic and operational experience of leading operations with international customers. He served most recently as CEO of Semcon, where he worked for 16 years.</p><p>“I am happy to have recruited Katarina as Chairman of TFS’s Board. Her extensive experience in senior management positions in the life science industry will enable her to add great value. It is also very positive that Markus has agreed to take on the role of acting CEO. We had a productive partnership during Markus’s time as President and CEO of Semcon, and we have worked together on the TFS Board for some time,” says Anders Slettengren, current Chairman of the TFS Board and Executive Vice President, Ratos.</p><p><strong>About TFS HealthScience</strong><br>TFS HealthScience is a global Contract Research Organisation (CRO) that supports biotechnology and pharmaceutical companies throughout their entire clinical development journey. Bringing together nearly 700 professionals, TFS delivers tailored clinical research services in more than 40 countries and supports customers with comprehensive solutions through three strong business models: Clinical Development Services (CDS), which provides full-service support at all stages of the clinical development process, Strategic Resourcing Solutions (SRS), which offers expert insourcing and targeted recruitment services, and Functional Services (FSP), to provide customers with strategic outsourcing solutions.</p></div><div class="mfn-footer mfn-contacts mfn-7ea391644893"><p><strong class="mfn-heading-1">For more information, please contact:</strong><br>Josefine Uppling, VP Communication &amp; Sustainability, Ratos, +46 76 114 54 21</p></div><div class="mfn-footer mfn-about mfn-87cad36da2b7"><p><strong class="mfn-heading-1">About Ratos</strong><br><em>Ratos is a Swedish business group focusing on technological and infrastructure solutions, consisting of 15 companies divided into three business areas: Construction &amp; Services, Industry and Consumer. The companies have approximately SEK 32 billion in net sales (December LTM). We have a distinct corporate culture and strategy – everything we do is based on our core values: Simplicity, Speed in Execution and It’s All About People. We enable independent subsidiaries to excel by being part of something larger. People, leadership, culture and values are key focus areas.</em></p></div><div class="mfn-footer mfn-attachment mfn-attachment-general"><p><strong class="mfn-heading-1">Attachments</strong><br><a rel="noopener" href="https://storage.mfn.se/0c04eda3-fcd6-4619-8734-a9a00238bd16/press-release.pdf" class="mfn-generated mfn-primary">Press release</a></p></div>

Katarina Ageborg new Chairman of the Board and Markus Granlund new acting CEO of TFS HealthScience